Boost for global response to COVID-19 as economies worldwide formally sign up to COVAX facility
64 higher income economies have joined the COVAX Facility, a global initiative that brings together governments and manufacturers to ensure eventual COVID-19 vaccines reach those in greatest need, whoever they are and wherever they live. These 64 economies include commitments from 35 economies as well as the European Commission which will procure doses on behalf of 27 EU member states plus Norway and Iceland. 73,000 Scientists collaborate over new COVID-19 Data Portal to speed up vaccine development
A new website that allows scientists to share difficult-to-find SARS-CoV-2 data from clinical trials, research centres, hospitals and national healthcare systems, has seen thousands of users collaborating to help beat the novel coronavirus.
Oxford COVID-19 vaccine programme opens for clinical trial recruitment
NIH to launch public-private partnership to speed COVID-19 vaccine and treatment options
New guidelines on caring for ICU patients with COVID-19
FDA approves first plasma therapy for Houston Methodist COVID-19 patient
More Pharma News ...
Business & Industry
- Bayer supports rebuilding of Ukrainian healthcare system by donating 1.3 million euros
- Eisai and Biogen announced the results from large global Phase 3 confirmatory Clarity AD clinical study of lecanemab
- AstraZeneca to acquire Neogene Therapeutics, accelerating ambition in Oncology cell therapy
- Pfizer and BioNTech report new data on Omicron BA.4/BA.5-adapted bivalent booster
- GSK announces positive Phase IIa study results for a new first-in-class candidate medicine for patients with tuberculosis
Research & Development
- Nanotech strategy shows promise for treating autoimmune disease
- The first potent COQ8 inhibitor targets ubiquinone biosynthesis
- AI tailors artificial DNA for future drug development
- Remdesivir reduces COVID-19 mortality in a real-world setting
- Pocket feature shared by deadly coronaviruses could lead to pan-coronavirus antiviral treatment
- Cryptic drug-binding sites discovered in the dance
- Unusual type of antibody shows ultrapotent activity against Zika
Conferences & Events
- 14th Annual RNA Therapeutics: Investigating the next generation of genetic medicine through RNA based therapies
- CPHI Excellence in Pharma Award Winners 2022
- CPHI Frankfurt Report predicts huge funding overhang to drive contract services growth
- CPHI Frankfurt 2022: Global pharma confidence hits record high in the annual CPHI Pharma Index
- SAE Media Group proudly presents the 2nd Annual Aseptic Processing Conference
- Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
- SMi's 22nd Annual Pain Therapeutics Conference
Regulatory Affairs
- FDA approves first gene therapy to treat adults with Hemophilia B
- FDA approves first treatment for Acid Sphingomyelinase Deficiency, a rare genetic disease
- FDA approves first systemic treatment for alopecia areata
- FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
- FDA limits use of Janssen COVID-19 vaccine to certain individuals